Cargando…
Timing of COVID-19 vaccine approval and endorsement by public figures
The global spread of COVID-19 has created an urgent need for a safe and effective vaccine. However, in the United States, the politicization of the vaccine approval process, including which public figures are endorsing it, could undermine beliefs about its safety and efficacy and willingness to rece...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744009/ https://www.ncbi.nlm.nih.gov/pubmed/33390295 http://dx.doi.org/10.1016/j.vaccine.2020.12.048 |
_version_ | 1783624347749974016 |
---|---|
author | Bokemper, Scott E. Huber, Gregory A. Gerber, Alan S. James, Erin K. Omer, Saad B. |
author_facet | Bokemper, Scott E. Huber, Gregory A. Gerber, Alan S. James, Erin K. Omer, Saad B. |
author_sort | Bokemper, Scott E. |
collection | PubMed |
description | The global spread of COVID-19 has created an urgent need for a safe and effective vaccine. However, in the United States, the politicization of the vaccine approval process, including which public figures are endorsing it, could undermine beliefs about its safety and efficacy and willingness to receive it. Using a pair of randomized survey experiments, we show that announcing approval of a COVID-19 vaccine one week before the presidential election compared to one week after considerably reduces both beliefs about its safety and efficacy and intended uptake. However, endorsement by Dr. Anthony Fauci increases confidence and uptake among all partisan subgroups. Further, an endorsement by Dr. Fauci increased uptake and confidence in safety even if a vaccine receives pre-election approval. The results here suggest that perceptions of political influence in COVID-19 vaccine approval could significantly undermine the viability of a vaccine as a strategy to end the pandemic. |
format | Online Article Text |
id | pubmed-7744009 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-77440092020-12-17 Timing of COVID-19 vaccine approval and endorsement by public figures Bokemper, Scott E. Huber, Gregory A. Gerber, Alan S. James, Erin K. Omer, Saad B. Vaccine Article The global spread of COVID-19 has created an urgent need for a safe and effective vaccine. However, in the United States, the politicization of the vaccine approval process, including which public figures are endorsing it, could undermine beliefs about its safety and efficacy and willingness to receive it. Using a pair of randomized survey experiments, we show that announcing approval of a COVID-19 vaccine one week before the presidential election compared to one week after considerably reduces both beliefs about its safety and efficacy and intended uptake. However, endorsement by Dr. Anthony Fauci increases confidence and uptake among all partisan subgroups. Further, an endorsement by Dr. Fauci increased uptake and confidence in safety even if a vaccine receives pre-election approval. The results here suggest that perceptions of political influence in COVID-19 vaccine approval could significantly undermine the viability of a vaccine as a strategy to end the pandemic. Elsevier Ltd. 2021-01-29 2020-12-16 /pmc/articles/PMC7744009/ /pubmed/33390295 http://dx.doi.org/10.1016/j.vaccine.2020.12.048 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Bokemper, Scott E. Huber, Gregory A. Gerber, Alan S. James, Erin K. Omer, Saad B. Timing of COVID-19 vaccine approval and endorsement by public figures |
title | Timing of COVID-19 vaccine approval and endorsement by public figures |
title_full | Timing of COVID-19 vaccine approval and endorsement by public figures |
title_fullStr | Timing of COVID-19 vaccine approval and endorsement by public figures |
title_full_unstemmed | Timing of COVID-19 vaccine approval and endorsement by public figures |
title_short | Timing of COVID-19 vaccine approval and endorsement by public figures |
title_sort | timing of covid-19 vaccine approval and endorsement by public figures |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744009/ https://www.ncbi.nlm.nih.gov/pubmed/33390295 http://dx.doi.org/10.1016/j.vaccine.2020.12.048 |
work_keys_str_mv | AT bokemperscotte timingofcovid19vaccineapprovalandendorsementbypublicfigures AT hubergregorya timingofcovid19vaccineapprovalandendorsementbypublicfigures AT gerberalans timingofcovid19vaccineapprovalandendorsementbypublicfigures AT jameserink timingofcovid19vaccineapprovalandendorsementbypublicfigures AT omersaadb timingofcovid19vaccineapprovalandendorsementbypublicfigures |